Health Advances Blog

Reflections on Healthcare & Life Sciences Innovation

Skip to content
Menu
  • Home
  • About
  • COVID-19 Impact
  • Visit Our Website
  • Contact Us

Category: Asia/APAC Markets

Reflections on BIOHK2022: Asia Biotech Market and the 2023 Outlook
  • by healthadvances
  • Posted on January 13, 2023

Reflections on BIOHK2022: Asia Biotech Market and the 2023 Outlook

Read More
Digital Health in Japan and Korea – Where Is It Heading?
  • by healthadvances
  • Posted on May 4, 2022

Digital Health in Japan and Korea – Where Is It Heading?

Read More
Rise of Innovative Medtech in APAC
  • by healthadvances
  • Posted on April 4, 2022April 5, 2022

Rise of Innovative Medtech in APAC

Read More
India Biosimilars
  • by healthadvances
  • Posted on July 21, 2021

India, the Generic Manufacturing Powerhouse, Biosimilar Next?

Read More
China Health
  • by healthadvances
  • Posted on June 30, 2021

Tencent-Backed Wedoctor Is Going Public: What Are the Next Steps for Chinese Digital Health Companies?

Read More
  • by healthadvances
  • Posted on September 15, 2020

Hong Kong Exchange: Nurturing China’s Biotech Valley

Read More
  • by healthadvances
  • Posted on May 8, 2020

How COVID-19 is Accelerating Telemedicine Adoption in Asia Pacific

Read More
  • by healthadvances
  • Posted on April 16, 2020April 16, 2020

US SARS-CoV-2 Testing Response: What can be learned from South Korea and Germany?

Read More
  • by healthadvances
  • Posted on April 13, 2020April 20, 2020

Medtech Geographic Launch Sequences Warrant Reevaluation

Read More
  • by healthadvances
  • Posted on March 30, 2020April 13, 2020

Key Trends and Developments in the Chinese Oncology Market

Read More
  • by healthadvances
  • Posted on December 4, 2019April 13, 2020

Australian Biotechs and Medtechs: Look to the East

Read More
  • by healthadvances
  • Posted on November 18, 2019April 13, 2020

Changes in China: How Can Medtech Companies Succeed? (Part Two)

Read More
  • by healthadvances
  • Posted on November 11, 2019April 13, 2020

Changes in China: How Can Medtech Companies Succeed? (Part One)

Read More
  • by healthadvances
  • Posted on April 16, 2019April 13, 2020

Better Market Access in China – Government Improves Pricing and Reimbursement Environment

Read More
  • by healthadvances
  • Posted on April 7, 2019April 13, 2020

Keytruda, a case study for the improved regulatory environment in China

Read More
  • by healthadvances
  • Posted on March 27, 2019April 13, 2020

Improvements in China Drug Registration – Opening the Door to the China Market for Global BioPharma

Read More
  • by healthadvances
  • Posted on November 9, 2018April 13, 2020

Health Advances Presentation at ISPOR: An Initial Analysis of the Cost-Based Pricing Revisions in Japan

Read More

Stay Connected

Enter your email address to subscribe to Health Advances blog and receive notifications of new posts by email.

We use WordPress as our blog publishing platform. By entering your email address, you acknowledge that the information you provide will be transferred to WordPress for processing in accordance with their Privacy Policy and Terms.

Topics of Interest

  • Asia/APAC Markets
  • BioPharma
  • COVID-19
  • Diagnostics and Life Science Tools
  • European Markets
  • Health IT and Digital Health
  • Investors
  • Launch Excellence
  • Market Access & Health Policy
  • MedTech
  • Other

Search Our Blog

Follow Us on Social Media

  • View healthadvances’s profile on Facebook
  • View @healthadvances’s profile on Twitter
  • LinkedIn

Recent Tweets

My Tweets
This website uses cookies. You may choose to continue browsing with cookies or leave the site.

Health Advances Privacy Policy
Create a website or blog at WordPress.com
 

Loading Comments...